Tom Luedde
@tom_luedde
Clinician scientist @UniklinikDUS. Working on molecular and clinical aspects of liver disease and GI cancer. Views are my own. #livertwitter
ID: 827459116264259584
03-02-2017 10:10:01
507 Tweet
1,1K Followers
1,1K Following
Out in Journal of Hepatology : KIF23 and miR-107 control replicative fitness in hepatocellular carcinoma and might be a new therap. target. Thanks to all collaborators and funders! journal-of-hepatology.eu/article/S0168-… EASL Education EASLnews HHU_Medizin Uniklinik Düsseldorf Mathias Heikenwälder DFG public | @[email protected] IfADo